Dr. Daniel Alcolea obtained his Medical Degree at Universidad de Navarra in 2003 and specialized in Neurology at Hospital de la Santa Creu i Sant Pau (Barcelona). He received his PhD from Universitat Autònoma de Barcelona (UAB) with a thesis focused on cerebrospinal fluid biomarkers for the study of the pathophysiological pathways in Alzheimer’s disease. His main responsibilities as a faculty neurologist at the Neurology Department are the evaluation, diagnosis and treatment of patients with memory problems. His main research interests are the discovery and development of cerebrospinal fluid biomarkers for the early and accurate diagnosis of neurodegenerative diseases. Dr. Alcolea also collaborates at the UAB Medical School as an associate clinical teacher.
